促肝细胞生长素治疗重型肝炎的疗效评价

An Evaluation of Prompting Hepatocyte Growth Factor (pHGF) on Advanced Viral Hepatitis

应用从新生公牛肝脏制备的促肝细胞生长素治疗重型肝炎３７例，存活率６４．８６％，与对照组存活率３１．２５％相比有显著性差异（Ｐ＜０．０１）。具体方法为促肝细胞生长素１００～１２０ｍｇ加入１０％葡萄糖液２５０ｍｌ静滴，２个月为一疗程。本品使用安全，无毒副作用，为治疗重型肝炎较为理想的药物。此外，还对促肝细胞生长素的命名、生物学特性以及临床应用作了讨论。

The effects of pHGF derived from newborn calves on patients with advanced viral hepatitis were observed. The results showed that total survival rate were 64.86% (24/37) in the pHGF treatment group and 31.25% (10/32) in the control group ( P <0.01). It is suggested that pHGF could greatly elevate the survival rate of the patients with advanced viral hepatitis.